Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Michael

Showing results (271-280 of 303) with videos related to

Pageof 31
Sort By:
Oncotarget|April 28, 2015
HER-2 and HER-3 expression in liver metastases of patients with colorectal cancerHanna Styczen, Iris Nagelmeier, Tim Beissbarth, et al.
Frontiers in Neuroscience|July 11, 2014
A neurochemical closed-loop controller for deep brain stimulation: toward individualized smart neuromodulation therapiesPeter J Grahn, Grant W Mallory, Obaid U Khurram, et al.
Carcinogenesis|November 25, 2022
Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patientsShouhui Yang, Wei Tang, Azadeh Azizian, et al.
Cancer Research|January 16, 2013
Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancerJordi Camps, Jason J Pitt, Georg Emons, et al.
Cancers|February 3, 2021
NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to ChemoradiotherapyKristin Koerdel, Melanie Spitzner, Thomas Meyer, et al.
Case Reports in Oncology|January 30, 2014
Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse EventHenriette Quack, Luise Erpenbeck, Hendrik A Wolff, et al.
Oncotarget|July 2, 2016
Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancerJian Wang, Peijun He, Matthias Gaida, et al.
Plos One|February 25, 2012
DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinomaGeng Zhang, Aaron Schetter, Peijun He, et al.
Molecular Cancer Research : MCR|August 17, 2017
Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin SignalingGeorg Emons, Melanie Spitzner, Sebastian Reineke, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 23, 2013
Biaryl amides and hydrazones as therapeutics for prion disease in transgenic miceDuo Lu, Kurt Giles, Zhe Li, et al.
Pageof 31

Showing results (271-280 of 303) with videos related to

Sort By:
Pageof 31
Oncotarget|April 28, 2015
HER-2 and HER-3 expression in liver metastases of patients with colorectal cancerHanna Styczen, Iris Nagelmeier, Tim Beissbarth, et al.
Frontiers in Neuroscience|July 11, 2014
A neurochemical closed-loop controller for deep brain stimulation: toward individualized smart neuromodulation therapiesPeter J Grahn, Grant W Mallory, Obaid U Khurram, et al.
Carcinogenesis|November 25, 2022
Dysregulation of HNF1B/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer patientsShouhui Yang, Wei Tang, Azadeh Azizian, et al.
Cancer Research|January 16, 2013
Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancerJordi Camps, Jason J Pitt, Georg Emons, et al.
Cancers|February 3, 2021
NOTCH Activation via gp130/STAT3 Signaling Confers Resistance to ChemoradiotherapyKristin Koerdel, Melanie Spitzner, Thomas Meyer, et al.
Case Reports in Oncology|January 30, 2014
Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse EventHenriette Quack, Luise Erpenbeck, Hendrik A Wolff, et al.
Oncotarget|July 2, 2016
Inducible nitric oxide synthase enhances disease aggressiveness in pancreatic cancerJian Wang, Peijun He, Matthias Gaida, et al.
Plos One|February 25, 2012
DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinomaGeng Zhang, Aaron Schetter, Peijun He, et al.
Molecular Cancer Research : MCR|August 17, 2017
Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin SignalingGeorg Emons, Melanie Spitzner, Sebastian Reineke, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 23, 2013
Biaryl amides and hydrazones as therapeutics for prion disease in transgenic miceDuo Lu, Kurt Giles, Zhe Li, et al.
Pageof 31